Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04305496 |
|---|---|
| Brief Title: | Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer (CAPItello-291) |
| First Submitted : | February 20, 2020 |
| First Submitted that Met QC Criteria : | March 11, 2020 |
| First Posted : | March 12, 2020 |
| Last Update Submitted that Met QC Criteria : | February 19, 2021 |
| Last Update Posted : | February 21, 2021 |